glp 1 preauthorization movement benefit Long-term Success of GLP-1s Hinges on More Than Just a Prescription Big policy shift in obesity

CVS is also seeing stronger GLP-1 usage thats creating a yin-and-yang dynamic between its insurance and pharmacy businesses

Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, Aizenberg D, Wynne AG, Riesmeyer JS, Heine RJ, et al

The pill form of the medication works the same way as the injectable GLP-1s

On the other hand, the clinical trials on semaglutide (Wegovy) for weight loss have been clear: On average, people taking that medication lose 15% of their body weight over 68 weeks compared to 2.4% of body weight in those taking a placebo

The total effect is nevertheless meaningful (OR = 0.59,95% CI: 0.390.89, P = 0.0109), indicating that there is a significant causal association between GLP-1RA and DR risk reduction in the European population

To explain, we have to start in the weeds